Modern radiation therapy for Hodgkin lymphoma: Field and dose guidelines from the international lymphoma radiation oncology group (ILROG)

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 4, 2014, Pages 854-862

  Specht, Lena ^a   Yahalom, Joachim ^b   Illidge, Tim ^c   Berthelsen, Anne Kiil ^a   Constine, Louis S ^d   Eich, Hans Theodor ^e   Girinsky, Theodore ^f   Hoppe, Richard T ^g   Mauch, Peter ^h   Mikhaeel, N George ⁱ   Ng, Andrea ^h  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g STANFORD UNIVERSITY   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; MAGNETIC RESONANCE IMAGING; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIATION; RADIOTHERAPY; TUMORS;

CLINICAL TARGET VOLUMES; COMBINED MODALITY THERAPY; COMBINED MODALITY TREATMENT; IMAGE-GUIDED RADIATION THERAPY; INTENSITY MODULATED RADIATION THERAPY; INTERNATIONAL COMMISSION; PLANNING TARGET VOLUMES; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES;

DISEASE CONTROL;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST; CONTRAST ENHANCED COMPUTED TOMOGRAPHY; DISEASE CONTROL; HODGKIN DISEASE; HUMAN; IMAGE GUIDED RADIOTHERAPY; IMMOBILIZATION; INTENSITY MODULATED RADIATION THERAPY; MULTIMODALITY CANCER THERAPY; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANS AT RISK; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TISSUE INJURY; TOMOTHERAPY; TREATMENT PLANNING; TUMOR VOLUME;

HODGKIN DISEASE; HUMANS; LYMPH NODES; LYMPHATIC IRRADIATION; MULTIMODAL IMAGING; ORGANS AT RISK; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; TUMOR BURDEN;

EID: 84903272543     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.05.005     Document Type: Review

References (27)

1. M.V. Maraldo, M.C. Aznar, and I.R. Vogelius et al. Involved node radiotherapy: An effective alternative in early stage Hodgkin lymphoma Int J Radiat Oncol Biol Phys 85 2013 1057 1065
2. J. Yahalom, and P. Mauch The involved field is back: Issues in delineating the radiation field in Hodgkin's disease Ann Oncol 13 Suppl 1 2002 79 83
3. P. DeLuca, D. Jones, and R. Gahbauer et al. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT) J ICRU 10 2010 1 106
4. M.P.E. Andre, O. Reman, and M. Federico et al. Interim analysis of the randomized EORTC/LYSA/FIL intergroup H10 trial on early PET-scan driven treatment adaptation in stage I/II Hodgkin lymphoma [Abstract] Blood 120 2012 549
5. J. Radford, S. Barrington, and N. Counsell et al. Involved field radiotherapy versus no further treatment in patients with clinical stages IA and IIA Hodgkin lymphoma and a 'negative' PET scan after 3 cycles ABVD. Results of the UK NCRI RAPID trial [Abstract] Blood 120 2012 547
6. A. Engert, A. Plutschow, and H.T. Eich et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma N Engl J Med 363 2010 640 652
7. C. Herbst, F.A. Rehan, and C. Brillant et al. Combined modality treatment improves tumour control and overall survival in patients with early stage Hodgkin lymphoma: a systematic review Haematologica 95 2010 494 500
8. N.L. Bartlett, S.A. Rosenberg, and R.T. Hoppe et al. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: A preliminary report J Clin Oncol 13 1995 1080 1088
9. ICRU. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon therapy. (Supplement to ICRU Report 50). ICRU Report 62. 1999.
10. M. van Herk Errors and margins in radiotherapy Semin Radiat Oncol 14 2004 52 64
11. H.T. Eich, V. Diehl, and H. Gorgen et al. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial J Clin Oncol 28 2010 4199 4206
12. A. Wirth, K. Yuen, and M. Barton et al. Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: A retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group Cancer 104 2005 1221 1229
13. A.K. Berthelsen, S. Holm, and A. Loft et al. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients Eur J Nucl Med Mol Imaging 32 2005 1167 1175
14. K.A. Goodman, S. Toner, and M. Hunt et al. Intensity-modulated radiotherapy for lymphoma involving the mediastinum Int J Radiat Oncol Biol Phys 62 2005 198 206
15. A. Paumier, M. Ghalibafian, and J. Gilmore et al. Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 82 2012 1522 1527
16. N.P. Brodin, I.R. Vogelius, and M.V. Maraldo et al. Life years lost: Comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale Cancer 118 2012 671 676
17. L.B. Marks, R.K. Ten Haken, and M.K. Martel et al. Quantitative analyses of normal tissue effects in the clinic Int J Radiat Oncol Biol Phys 76 2012 1 160
18. T. Girinsky, R. van der Maazen, and L. Specht et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines Radiother Oncol 79 2006 270 277
19. T. Girinsky, M. Ghalibafian, and L. Specht Target definition for Hodgkin lymphoma: The involved node radiation field concept L. Specht, J. Yahalom, Radiotherapy for Hodgkin Lymphoma 2011 Springer Heidelberg 91 122
20. T. Girinsky, L. Specht, and M. Ghalibafian et al. The conundrum of Hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines Radiother Oncol 88 2008 202 210
21. M. Hutchings, A. Loft, and M. Hansen et al. Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma Haematologica 91 2006 482 489
22. A. Paumier, M. Ghalibafian, and A. Beaudre et al. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma Int J Radiat Oncol Biol Phys 80 2011 199 205
23. L. Nogova, T. Reineke, and H.T. Eich et al. Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: A retrospective analysis from the German Hodgkin Study Group (GHSG) Ann Oncol 16 2005 1683 1687
24. A. Josting, L. Nogova, and J. Franklin et al. Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: A retrospective analysis from the German Hodgkin Lymphoma Study Group J Clin Oncol 23 2005 1522 1529
25. J.S. Goda, C. Massey, and J. Kuruvilla et al. Role of salvage radiation therapy for patients with relapsed or refractory Hodgkin lymphoma who failed autologous stem cell transplant Int J Radiat Oncol Biol Phys 84 2012 e329 e335
26. J.M. Vose, P.J. Bierman, and J.R. Anderson et al. Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: Clinical course and patient follow-up Blood 80 1992 2142 2148
27. C.H. Moskowitz, S.D. Nimer, and A.D. Zelenetz et al. A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model Blood 97 2001 616 623